Diagnosis of TB disease by National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
TB Elimination
Diagnosis of Tuberculosis Disease
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
CS227840_C
When Should You Suspect 
Tuberculosis (TB)?
TB is a disease caused by Mycobacterium 
tuberculosis. TB disease should be suspected in 
persons who have the following symptoms:
 • Unexplained weight loss 
 • Loss of appetite 
 • Night sweats 
 • Fever 
 • Fatigue 
If TB disease is in the lungs (pulmonary), 
symptoms may include: 
 • Coughing for ≥3 weeks 
 • Hemoptysis (coughing up blood) 
 • Chest pain 
If TB disease is in other parts of the body 
(extrapulmonary), symptoms will depend on  
the area affected.
How Do You Evaluate Persons 
Suspected of Having TB Disease?
A complete medical evaluation for TB includes 
the following:
1. Medical History
Clinicians should ask about the patient’s 
history of TB exposure, infection, or disease. 
It is also important to consider demographic 
factors (e.g., country of origin, age, ethnic or 
racial group, occupation) that may increase the 
patient’s risk for exposure to TB or to drug-
resistant TB. Also, clinicians should determine 
whether the patient has medical conditions, 
especially HIV infection, that increase the risk 
of latent TB infection progressing to TB disease. 
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2. Physical Examination
A physical exam can provide valuable 
information about the patient’s overall 
condition and other factors that may affect 
how TB is treated, such as HIV infection or  
other illnesses. 
3. Test for TB Infection
The Mantoux tuberculin skin test (TST) or  
the TB blood test can be used to test for  
M. tuberculosis infection. Additional tests are 
required to confirm TB disease. The Mantoux 
tuberculin skin test is performed by injecting 
a small amount of fluid called tuberculin into 
the skin in the lower part of the arm. The test 
is read within 48 to 72 hours by a trained 
health care worker, who looks for a reaction 
(induration) on the arm.
The TB blood test measures the patient’s 
immune system reaction to M. tuberculosis.
4. Chest Radiograph
A posterior-anterior chest radiograph is used 
to detect chest abnormalities. Lesions may 
appear anywhere in the lungs and may differ 
in size, shape, density, and cavitation. These 
abnormalities may suggest TB, but cannot be 
used to definitively diagnose TB. However, a 
chest radiograph may be used to rule out the 
possibility of pulmonary TB in a person who 
has had a positive reaction to a TST or TB blood 
test and no symptoms of disease. 
5. Diagnostic Microbiology
The presence of acid-fast-bacilli (AFB) 
on a sputum smear or other specimen 
often indicates TB disease. Acid-fast 
microscopy is easy and quick, but it 
does not confirm a diagnosis of TB 
because some acid-fast-bacilli are not 
M. tuberculosis. Therefore, a culture is 
done on all initial samples to confirm the 
diagnosis. (However, a positive culture 
is not always necessary to begin or 
continue treatment for TB.) A positive 
culture for M. tuberculosis confirms 
the diagnosis of TB disease. Culture 
examinations should be completed on 
all specimens, regardless of AFB smear 
results. Laboratories should report 
positive results on smears and cultures 
within 24 hours by telephone or fax to 
the primary health care provider and to 
the state or local TB control program, as 
required by law. 
6. Drug Resistance
For all patients, the initial M. tuberculosis 
isolate should be tested for drug 
resistance. It is crucial to identify drug 
resistance as early as possible to ensure 
effective treatment. Drug susceptibility 
patterns should be repeated for patients 
who do not respond adequately to 
treatment or who have positive culture 
results despite 3 months of therapy. 
Susceptibility results from laboratories 
should be promptly reported to the 
primary health care provider and the 
state or local TB control program. 
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